Survodutide 10 mg
$85.00
Dual GCGR/GLP-1R agonist with optimized receptor selectivity. ≥98% purity, 10 mg lyophilized. For laboratory research only.
- 🔒 Secure Checkout
- ↩️ 30-Day Easy Returns
- ⭐ Premium Quality Guaranteed
🛍️ Frequently Bought Together
🔒Secure Checkout
🚚Fast Shipping
↩️Easy Returns
✅Quality Guaranteed
Description
Survodutide (BI 456906) is a dual glucagon/GLP-1 receptor agonist peptide developed for advanced metabolic research.
Research Profile
Featuring optimized receptor selectivity ratios between GLP-1R and GCGR, Survodutide has been investigated in Phase II and III clinical trials for metabolic conditions. Its unique pharmacological profile enables researchers to study the synergistic effects of coordinated incretin and glucagon receptor engagement on energy expenditure and hepatic lipid metabolism.
Dual GCGR/GLP-1R AgonistOptimized Selectivity10 mg Lyophilized≥98% Purity
This product is not a drug, dietary supplement, or food. It is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding biological activity, outcomes, or effects. By purchasing this product, the buyer acknowledges that it is for research use only and agrees to handle, store, and dispose of it in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.